Target intelligence / Profile preview

microRNA 320e (MIR320E)

Target
MIR320E
Molecular classification
microRNA, small non-coding RNA
01

Overview

microRNA 320e (MIR320E) is a non-coding RNA gene located within intron 3 of the PRKD2 gene on chromosome 19q13.32 in humans. It is part of the miR-320 family, whose members function as tumor suppressors by inhibiting proliferation, inducing cell cycle arrest, and modulating EMT in multiple cancer types. MIR320E acts by post-transcriptional regulation of various putative target genes, including those with tumor-suppressor functions (e.g., PP2R2C, IRF6, ONECUT2, CPEB2). Elevated expression of MIR320E has been associated with poorer outcomes in colorectal cancer, indicating a role as a negative prognostic biomarker. The full scope of its mechanistic role and regulated pathways remains under investigation, and direct therapeutic targeting has not yet entered clinical practice.

Other names
hsa-mir-320eMIR320EmiR-320e
02

Mechanism of action

As a microRNA, MIR320E regulates gene expression by binding to target mRNAs, typically resulting in inhibition of protein translation or promotion of mRNA degradation. Indirect mechanisms involve suppression of cell proliferation and modulation of EMT.

03

Biological functions

Post-transcriptional regulation of gene expressionCell proliferation controlModulation of apoptosisPotential regulation of epithelial-mesenchymal transition (EMT)
04

Disease associations

Cancer (e.g., colorectal cancer)Cancer (other tumors as part of the miR-320 family)Cardiovascular disease (modulation in ischemic heart, roles in apoptosis in cardiomyocytes)Possible roles in hydrocephalusReproductive system disorders (by analogy to family members)
05

Safety considerations

None specifically documented for targeting or modulating MIR320E.General concerns with targeting microRNAs can include potential off-target effects and widespread changes in gene expression, given the diverse set of target mRNAs.
06

Biomarkers

Prognostic biomarker for disease-free survival and overall survival in colorectal cancer patients, especially those treated with 5-FU-based chemotherapy

Beyond the preview

Go deeper on microRNA 320e (MIR320E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 320e (MIR320E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call